Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03813862 · ClinicalTrials.gov registry record
Observational Pharmaco-Epidemiology Research & Analysis
A clinical trial of Cardiovascular Diseases and HIV/AIDS, sponsored by Epividian.
- Recruiting
- Registry status
- 2,000,000
- Enrollment target
- 1
- Study location
NCT03813862: Recruiting study of Cardiovascular Diseases and HIV/AIDS, sponsored by Epividian.
NCT03813862 is a study of Cardiovascular Diseases and HIV/AIDS that is actively recruiting participants, run by Epividian. The registered enrollment target is 2,000,000 participants, above the 20,308-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (9748% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03813862, a study of Cardiovascular Diseases and HIV/AIDS, is actively recruiting participants, sponsored by Epividian.
- RECRUITING
- Registry status
- 2,000,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider-patient encounter that support realworld medical research and healthcare quality measure assessment. Real-world evaluations of treatments of chronic diseases in the context of comorbid conditions and special populations (minorities, women, mentally ill, and those with addiction) are limited. The purpose of the OPERA database is to help address this unmet need in clinical research.
Conditions Studied
Interventions
- OTHER Non-interventional (observational only)
Study Locations (1)
North Carolina
- Epividian - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000,000 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2035-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03813862
The ClinicalTrials.gov registry entry for NCT03813862 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 20,308-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (9748% higher). The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional (observational only) is the first listed.
NCT03813862 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03813862 about?
NCT03813862 is a clinical study titled "Observational Pharmaco-Epidemiology Research & Analysis". Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider...
What is the current status of trial NCT03813862?
This trial is currently recruiting. The enrollment target is 2,000,000 participants. The study started on 2013-12-01. Estimated completion is 2035-11.
What conditions does trial NCT03813862 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, HIV/AIDS, Inflammatory Bowel Diseases, Chronic Disease, Liver Diseases.
What interventions are being tested in trial NCT03813862?
The interventions under investigation include: Non-interventional (observational only) (OTHER).
Who is sponsoring clinical trial NCT03813862?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03813862 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.